| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |